Financial insights of IBIO

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	-	-	100	100*
Research and development	3,254	4,280	3,550	3,195*
General and administrative	5,111	5,165	2,501	2,029*
Total operating expenses	8,365	9,445	6,051	5,224*
Operating loss	-8,365	-9,445	-5,951	-5,124*
Interest income	657	493	267	69*
Interest expense	22	41	36	46*
Total other income (expense)	635	452	231	23*
Net loss from continuing operations	-	-	-	-5,102
Net loss	-7,730	-8,993	-5,720	-5,102
Other comprehensive loss - unrealized loss on on debt securities	-31	25	-15	-
Comprehensive loss	-7,761	-8,968	-5,735	-

Basic EPS	-0.06	-0.09	-0.11	-0.392
Diluted EPS	-0.06	-0.09	-0.11	-0.392
Basic Average Shares	119,600,000	99,133,000	52,981,000	13,002,000
Diluted Average Shares	119,600,000	99,133,000	52,981,000	13,002,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.